{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:49:46Z","timestamp":1789577386234,"version":"build-2803163510"},"reference-count":0,"publisher":"Termedia Sp. z.o.o.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["pdia"],"published-print":{"date-parts":[[2020]]},"DOI":"10.5114\/ada.2020.102107","type":"journal-article","created":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T22:57:34Z","timestamp":1612133854000},"page":"909-914","source":"Crossref","is-referenced-by-count":15,"title":["Clinical consequences of the presence of anti-RNA Pol III antibodies in systemic sclerosis"],"prefix":"10.5114","volume":"37","author":[{"given":"Ewa","family":"Wielosz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Dryglewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Majdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","container-title":["Advances in Dermatology and Allergology"],"original-title":[],"link":[{"URL":"https:\/\/www.termedia.pl\/doi_ft\/10.5114\/ada.2020.102107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T22:57:50Z","timestamp":1612133870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.termedia.pl\/doi\/10.5114\/ada.2020.102107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"alternative-id":["102107"],"URL":"https:\/\/doi.org\/10.5114\/ada.2020.102107","relation":{},"ISSN":["1642-395X"],"issn-type":[{"value":"1642-395X","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}